These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 36331145)
1. An assessment of the reliability of 52 enhanced preliminary embryofetal development studies to detect developmental toxicity. Barrow P Birth Defects Res; 2023 Jan; 115(2):218-223. PubMed ID: 36331145 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of rat and rabbit embryofetal development studies with pharmaceuticals: the added value of a second species. Roos P; Anggasta C; Piersma AH; van Meer PJK; Theunissen PT Crit Rev Toxicol; 2024 Oct; 54(9):619-633. PubMed ID: 39093553 [TBL] [Abstract][Full Text] [Related]
3. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2018 and 2019. Barrow P; Clemann N Reprod Toxicol; 2021 Jan; 99():144-151. PubMed ID: 32593570 [TBL] [Abstract][Full Text] [Related]
4. Analysis of exposure margins in developmental toxicity studies for detection of human teratogens. Andrews PA; Blanset D; Costa PL; Green M; Green ML; Jacobs A; Kadaba R; Lebron JA; Mattson B; McNerney ME; Minck D; Oliveira LC; Theunissen PT; DeGeorge JJ Regul Toxicol Pharmacol; 2019 Jul; 105():62-68. PubMed ID: 30981719 [TBL] [Abstract][Full Text] [Related]
5. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2022 and 2023. Barrow P Reprod Toxicol; 2024 Dec; 130():108727. PubMed ID: 39332698 [TBL] [Abstract][Full Text] [Related]
6. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2020 and 2021. Barrow P Reprod Toxicol; 2022 Sep; 112():100-108. PubMed ID: 35788364 [TBL] [Abstract][Full Text] [Related]
7. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2016 and 2017. Barrow P Reprod Toxicol; 2018 Sep; 80():117-125. PubMed ID: 29660390 [TBL] [Abstract][Full Text] [Related]
8. Fertility and developmental toxicity assessment in rats and rabbits with LY500307, a selective estrogen receptor beta (ERβ) agonist. Hilbish KG; Breslin WJ; Johnson JT; Sloter ED Birth Defects Res B Dev Reprod Toxicol; 2013 Oct; 98(5):400-15. PubMed ID: 24323950 [TBL] [Abstract][Full Text] [Related]
9. Exposure assessments in reproductive and developmental toxicity testing: An IQ-DruSafe industry survey on current practices and experiences in support of exposure-based high dose selection. Andrews PA; McNerney ME; DeGeorge JJ Regul Toxicol Pharmacol; 2019 Oct; 107():104413. PubMed ID: 31229519 [TBL] [Abstract][Full Text] [Related]
10. Investigation into the effect of microsampling on mouse fetuses and pregnant mice in the embryofetal development study design. Mitchard T; Kirk S; Grant C; Stewart J Reprod Toxicol; 2017 Jan; 67():140-145. PubMed ID: 28043866 [TBL] [Abstract][Full Text] [Related]
11. The predictivity of preliminary embryo-fetal development (EFD) studies: results of a retrospective survey in Japanese pharmaceutical companies. Okahashi N; Ikeda T; Kai S; Komatsu S; Matsui H; Yamashita Y; Yamamoto K; Sagami F J Toxicol Sci; 2010 Feb; 35(1):21-31. PubMed ID: 20118621 [TBL] [Abstract][Full Text] [Related]
12. Fertility and Embryo-Fetal Development Assessment in Rats and Rabbits with Evacetrapib: A Cholesteryl Ester Transfer Protein Inhibitor. Breslin WJ; Hilbish KG; Cannady EA; Edwards TL Birth Defects Res; 2017 Apr; 109(7):513-527. PubMed ID: 28398618 [TBL] [Abstract][Full Text] [Related]
13. Toward a comparative retrospective analysis of rat and rabbit developmental toxicity studies for pharmaceutical compounds. Theunissen PT; Beken S; Cappon GD; Chen C; Hoberman AM; van der Laan JW; Stewart J; Piersma AH Reprod Toxicol; 2014 Aug; 47():27-32. PubMed ID: 25517003 [TBL] [Abstract][Full Text] [Related]
14. Review of embryo-fetal developmental toxicity studies performed for recent FDA-approved pharmaceuticals. Ishihara-Hattori K; Barrow P Reprod Toxicol; 2016 Sep; 64():98-104. PubMed ID: 27112525 [TBL] [Abstract][Full Text] [Related]
15. Serial blood sampling effects in rat embryo-fetal development studies for toxicokinetics. Lee J; Jeong JS; Kim W; Kim SY; Lee SJ; Baek SK; Lee JH; Jeong EJ; Nam SY; Yu WJ Regul Toxicol Pharmacol; 2021 Jul; 123():104930. PubMed ID: 33891998 [TBL] [Abstract][Full Text] [Related]
16. Testing developmental toxicity in a second species: are the differences due to species or replication error? Braakhuis HM; Theunissen PT; Slob W; Rorije E; Piersma AH Regul Toxicol Pharmacol; 2019 Oct; 107():104410. PubMed ID: 31226390 [TBL] [Abstract][Full Text] [Related]
17. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Clark RL; White TE; A Clode S; Gaunt I; Winstanley P; Ward SA Birth Defects Res B Dev Reprod Toxicol; 2004 Dec; 71(6):380-94. PubMed ID: 15617018 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of developmental toxicity studies of glyphosate with attention to cardiovascular development. Kimmel GL; Kimmel CA; Williams AL; DeSesso JM Crit Rev Toxicol; 2013 Feb; 43(2):79-95. PubMed ID: 23286529 [TBL] [Abstract][Full Text] [Related]
19. Knockout mouse models are predictive of malformations or embryo-fetal death in drug safety evaluations. Catlin NR; Stethem CM; Bowman CJ; Campion SN; Nowland WS; Cappon GD Reprod Toxicol; 2020 Sep; 96():11-16. PubMed ID: 32522587 [TBL] [Abstract][Full Text] [Related]
20. Use of magnetic resonance imaging (MRI) and micro-computed tomography (micro-CT) in the morphological examination of rat and rabbit fetuses from embryo-fetal development studies. French J; Gingles N; Stewart J; Woodhouse N Reprod Toxicol; 2010 Sep; 30(2):292-300. PubMed ID: 20452417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]